Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hirotaka Takasaki
Lenvatinib as a Novel Treatment for Anaplastic Thyroid Cancer: A Retrospective Study
Oncology Letters
Cancer Research
Oncology
Renal Dysfunction in Patients With Radioactive Iodine-Refractory Thyroid Cancer Treated With Tyrosine Kinase Inhibitors
Medicine
Medicine
Related publications
Treatment With Lenvatinib to Anaplastic Thyroid Cancer :
JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
Lenvatinib vs. Palliative Therapy for Stage IVC Anaplastic Thyroid Cancer
Molecular and Clinical Oncology
Cancer Research
Oncology
Administration of Lenvatinib to Patients With Anaplastic Thyroid Cancer
JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
A Novel Therapeutic Approach for Anaplastic Thyroid Cancer Through Inhibition of LAT1
Scientific Reports
Multidisciplinary
Combining Doxorubicin-Nanobubbles and Shockwaves for Anaplastic Thyroid Cancer Treatment: Preclinical Study in a Xenograft Mouse Model
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Recent Progress of Genome Study for Anaplastic Thyroid Cancer
Genomics and Informatics
Evolution
Ecology
Genetics
Systematics
Health Informatics
Behavior
Methylglyoxal Acts as a Tumor-Promoting Factor in Anaplastic Thyroid Cancer
Cells
Budget Impact and Incremental Survival Benefit of Using Lenvatinib as a Treatment for Radioactive Iodine Refractory Differentiated Thyroid Cancer in Russia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Optimal Use of Lenvatinib in the Treatment of Advanced Thyroid Cancer
Cancers of the Head & Neck